The Research Engine for Claude
Connect your AI to a universe of discovery data. Instantly access 122M+ enriched molecules, scientific literature, patents, clinical trials, and more—with predictions, compliance, and context already waiting.
Works on Claude.ai (web), Claude Desktop, Claude Mobile, and Claude API.
NovoMCP uses OAuth for seamless authentication. No config files needed—just add the URL and authenticate in your browser.
Then ask Claude: "What's the ADMET profile of aspirin?"
Fifty properties per molecule. Hepatotoxicity, cardiotoxicity, CYP450 interactions, drug-likeness. No waiting for models—the answers are already computed and indexed for instant retrieval.
DEA, FDA, EPA, CWC, EU REACH. Eight jurisdictions checked in a single call. Controlled substance detection with 24 scaffold patterns. Context-aware assessment for intended use.
Compound not in our database? NovoMCP computes properties on-the-fly with RDKit and runs FAVES V3 regulatory screening. No molecule left behind.
Generate drug-like variants with NVIDIA MolMIM. Every output automatically screened—controlled substances never slip through.
3D protein structures from amino acid sequences via OpenFold3. Submit a sequence, receive a PDB file. Same API, no context switching.
Connect molecules to a world of context. Semantic search across 14,000+ curated papers, 2,400+ patents, plus the latest findings from bioRxiv, ChEMBL, and ClinicalTrials.gov.
21 tools, 5 resources, and 4 prompts across four access tiers.
Pay for what you use. 1 credit = $0.01. No subscriptions required.
NovoMCP exists because large language models need specialized tools for specialized domains. Drug discovery requires molecular intelligence that no general-purpose model can hold in context.
We built this as native MCP infrastructure—designed from the start to work alongside Claude and Anthropic's ecosystem. Not a wrapper around existing APIs. Purpose-built plumbing that gives AI assistants genuine capability in chemistry.
Join our design partner program. Help shape the future of AI-powered drug discovery.
Become a Design Partner